Chronic Migraine Epidemiology and Outcomes Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01648530|
Recruitment Status : Completed
First Posted : July 24, 2012
Results First Posted : January 29, 2015
Last Update Posted : January 29, 2015
|Condition or disease||Intervention/treatment|
|Migraine Disorders||Other: No Treatment|
|Study Type :||Observational|
|Actual Enrollment :||16789 participants|
|Study Start Date :||July 2012|
|Actual Primary Completion Date :||November 2013|
|Actual Study Completion Date :||November 2013|
Participants with Migraines
Participants who returned completed internet survey with positive screening for migraines. No intervention was administered in this study.
Other: No Treatment
- Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM) [ Time Frame: Baseline ]EM is defined as <15 headache days/month and CM is defined as ≥15 headache days/month.
- Migraine Disability Assessment (MIDAS) [ Time Frame: 12 Months ]The Midas score is a patient completed 5-item questionnaire about lost time and productivity (for work, school or family/social activities) in the past 3 months (number of days missed) where: 0-5=Little or No disability, 6-10=Mild disability, 11-20=Moderate disability or 21+ Severe disability. The Midas scores assessed at Months 3, 6, 9 and 12 were averaged.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01648530
|Study Director:||Medical Director||Allergan|